top of page
background_edited.jpg
Resources

GPAC Patient Decision Checklist

& Symptoms List for Mesh

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

 Mesh News (coming soon)

Surgical Mesh Groups/Pages/Resources

Mesh Removal Information 

Reporting Adverse Events 

Coming Soon...

Mesh Studies

Dr. Willem Cohen Tervaert | December 2018

Autoinflammatory/Autoimmunity Syndrome Induced by Adjuvants (ASIA): A New Flame

Dr. Alexander Galvin et al | March 2020

Imaging and Treatment of Complications of Abdominal and Pelvic Mesh Repair

Dr. Galvin et al | 2020

World Journal of Gastrointestinal Surgery Study | April 2015
Mesh Implants: An Overview of Crucial Mesh Parameters 
 

Lei-Ming Zhu et al | 2015

Dr. Eduardo Fleury | January 2021

The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma

Dr. Fleury Study | 2021

Dr. Arthur Brawer | 2019

The Clever Deception by Silicone Gel-filled Breast Implant Manufacturers Regarding the Phenomenon of GelBleed

Dr. Brawer Study | 2019

Dr. Brian Buinewicz | September 2021
Outcomes of Implant Removal and Capsulectomy for Breast Implant Illness in 248 Patients

Dr. Buinewicz Study | 2021

Dr. Lu-Jean Feng | September 1999
Analysis of Risk Factors Associated with Rupture of Silicone Gel Breast Implants
 

Dr. Feng Study | 1999

Dr. Lu-Jean Feng | April 2005
Pathology of Lymph Nodes From Patients with Breast Implants

Dr. Feng Study | 2005

Regulatory Announcements

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA April 2019 | FDA Orders Mesh Manufacturers to Stop Selling Devices for Tansvaginal Repair of Pelvic Organ Prolapse
FDA Stops Use of TVT

FDA September 2020 | Medical Device Reports for Systemic Symptoms in Women with Breast Implants

FDA January 2016 - FDA Strengthens Requirements for Pelvic Mesh 
FDA Strengthens Requirements for Pelvic Mesh

FDA September 2020 | 7 Things You Should Know About Breast Implants

UK MHRA 2014 - 7 Vaginal Mesh Implants: Summary of Benefits and Risks
UK Vaginal Mesh Implants

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma 

NHS England Mesh Working Group Report  - Mesh Oversight Report
UK Mesh Oversight Report

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma 

UK MHRA June 2022 | MHRA Future Regulation of Medical Devices in UK
UK Future Device Regulation

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma 

TGA November 2021 | Reclassification of Surgical Mesh Devices
TGA All Mesh Class 3 Devices

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

Global Regulatory Agencies

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA Food and Drug Administration (United States)
FDA (United States)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

Health Canada (Canada) 
Health Canada

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

MHRA Medicines and Heathcare products Regulatory Agency (United Kingdom)
MHRA (United Kingdom)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

TGA Therapeutic Goods Administration (Australia)
TGA (Australia)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

BfArM Federal Institute for Drugs and Medical Devices (Germany)
BfArM (Germany)
bottom of page